OUTLOOK THERAPEUTICS INC (OTLK)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $96.41M
Last updated: Nov 17, 2026 at 4:25 PM ET
OUTLOOK THERAPEUTICS INC (OTLK) Stock Chart
OUTLOOK THERAPEUTICS INC (OTLK) has a latest price of $0.36 on Nov 17, 2026, 85.8% below its 52-week high of $2.54. Its price fell 77.0% over the past 12 months. The month-end price fell 99.9% over the 10 years through Oct 2026, a compound annual decline of 51.7%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $673.60 in Oct 2016 and its lowest $0.21 in Mar 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart OTLK with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for OTLK.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 47.7%, and over 6 months it rose 57.9%. The month-end price fell 96.1% over the 3 years through Oct 2026, a compound annual decline of 66.1%.
| Period | Change |
|---|---|
| 1 month | -26.9% |
| 3 months | -47.7% |
| 6 months | +57.9% |
| 12 months | -77.0% |
| 12 months, with dividends | -77.0% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -96.1% | -66.1% |
| 5 years | -98.9% | -59.2% |
| 10 years | -99.9% | -51.7% |
Price by Year
Its best calendar year was 2020, when the price rose 120.3%, and its weakest was 2019, when it fell 85.3%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.47 | -70.4% |
| 2025 | $1.58 | -16.4% |
| 2024 | $1.89 | -76.0% |
| 2023 | $7.88 | -63.5% |
| 2022 | $21.60 | -20.6% |
| 2021 | $27.20 | +4.6% |
| 2020 | $26.00 | +120.3% |
| 2019 | $11.80 | -85.3% |
| 2018 | $80.00 | -61.5% |
| 2017 | $208.00 | -56.8% |
Trading Range
The price is 34.7% below its 50-day average of $0.55 and 45.3% below its 200-day average of $0.66.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.36 | |
| 52-week high | $2.54 | -85.8% |
| 52-week low | $0.16 | +124.0% |
| 50-day average | $0.55 | -34.7% |
| 200-day average | $0.66 | -45.3% |
Price Risk
Over 3 years, its largest fall from a peak was 98.3%.
| Measure | Value |
|---|---|
| 1-year beta | 1.36 |
| Largest fall, 1 year | -92.0% |
| Largest fall, 3 years | -98.3% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About OTLK
What is OTLK's 1-year price change?
OUTLOOK THERAPEUTICS INC's price fell 77.0% over the past 12 months. With dividends included, the 12-month total return was -77.0%.
What is OTLK's 5-year price change?
OUTLOOK THERAPEUTICS INC's month-end price fell 98.9% over the 5 years through Oct 2026, a compound annual decline of 59.2%. These figures leave out dividends.
What is OTLK's 52-week high and low?
OUTLOOK THERAPEUTICS INC's 52-week high is $2.54 and its 52-week low is $0.16. Its latest price of $0.36 on Nov 17, 2026 is 85.8% below the high.
What is OTLK's beta?
OUTLOOK THERAPEUTICS INC's 1-year beta against the S&P 500 is 1.36, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 92.0%.
Is the OTLK chart free?
Yes. Advanced Charting for OTLK is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
OTLK pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors